Kevin Ali - 05 May 2025 Form 4 Insider Report for Organon & Co. (OGN)

Role: Chief Executive Officer, Director
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Kevin Ali
Issuer symbol: OGN
Transactions as of: 05 May 2025
Net transactions value: +$299,370
Form type: 4
Filing time: 06 May 2025, 13:58:08 UTC
Previous filing: 02 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ali Kevin	Chief Executive Officer, Director	C/O ORGANON & CO., 30 HUDSON STREET, FLOOR 33, JERSEY CITY	/s/ Tarnetta V. Jones, as Attorney-in-Fact for Kevin Ali	06 May 2025	0001859698

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Purchase	$299,370	+34,000	+14%	$8.80	282,731	05 May 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.765 to $8.850, inclusive. The reporting person undertakes to provide to Organon & Co. ("Organon"), any security holder of Organon, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.765 to $8.850, inclusive. The reporting person undertakes to provide to Organon & Co. ("Organon"), any security holder of Organon, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.